| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 38, 1316-1321, Copyright © 1992 by American Association for Clinical Chemistry
MA Mansoor, AM Svardal, J Schneede and PM Ueland
Department of Pharmacology and Toxicology, University of Bergen, Haukeland Hospital, Norway.
We used a newly developed procedure to determine reduced, oxidized, and protein-bound forms of homocysteine, cysteine, cysteinylglycine, and glutathione to measure the plasma concentrations of these species during methionine loading in six young healthy men with normal fasting concentrations of plasma homocysteine and cysteine. The methionine loading induced a transient increase in total homocysteine, which peaked after approximately 6-8 h. All six subjects showed a concurrent significant increase in reduced homocysteine and cysteine, which peaked 2 h after loading, and a rapid decrease in protein-bound cysteine and cysteinylglycine. The concentration of reduced cysteinylglycine was not altered. Plots of protein-bound cysteine and cysteinylglycine vs total homocysteine formed hysteretic loops, showing a time-dependent relation between these analytes. After the initial decrease, protein-bound cysteine and cysteinylglycine showed a slight, transient increase. From 12 to 24 h after loading, protein-bound cysteine approached preloading concentrations in two subjects and declined further in four subjects. The response pattern was similar for cysteine and cysteinylglycine in each subject. Simple displacement could not account for these effects, which suggests that plasma homocysteine may affect the disposition of other thiols through complex mechanisms. The presence of reduced homocysteine and the dynamic relation that exists between homocysteine, cysteine, and related compounds in plasma should be taken into account when evaluating plasma homocysteine as an indicator or causative agent of human disease.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  A. I. Sergueeva, G. Y. Miasnikova, D. J. Okhotin, A. A. Levina, Z. Debebe, T. Ammosova, X. Niu, E. A. Romanova, S. Nekhai, P. M. DiBello, et al. Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation Haematologica, February 1, 2008; 93(2): 279 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Carmel, S. Melnyk, and S. J. James Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism Blood, April 15, 2003; 101(8): 3302 - 3308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Rossi, A. Milzani, I. Dalle-Donne, D. Giustarini, L. Lusini, R. Colombo, and P. Di Simplicio Blood Glutathione Disulfide: In Vivo Factor or in Vitro Artifact? Clin. Chem., May 1, 2002; 48(5): 742 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. RAGONE Homocystine solubility and vascular disease FASEB J, March 1, 2002; 16(3): 401 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. FRIEDMAN, A. G. BOSTOM, J. SELHUB, A. S. LEVEY, and I. H. ROSENBERG The Kidney and Homocysteine Metabolism J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2181 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Doshi, I. F. W. McDowell, S. J. Moat, D. Lang, R. G. Newcombe, M. B. Kredan, M. J. Lewis, and J. Goodfellow Folate Improves Endothelial Function in Coronary Artery Disease : An Effect Mediated by Reduction of Intracellular Superoxide? Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Williams, J. A. Maggiore, R. D. Reynolds, and C. M. Helgason Novel Approach for the Determination of the Redox Status of Homocysteine and Other Aminothiols in Plasma from Healthy Subjects and Patients with Ischemic Stroke Clin. Chem., June 1, 2001; 47(6): 1031 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Hortin, P. Sullivan, and G. Csako Relationships among Plasma Homocysteine, Cysteine, and Albumin Concentrations: Potential Utility of Assessing the Cysteine/Homocysteine Ratio Clin. Chem., June 1, 2001; 47(6): 1121 - 1124. [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Suliman, J. C. D. Filho, P. Barany, B. Anderstam, B. Lindholm, and J. Bergstrom Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients Nephrol. Dial. Transplant., January 1, 2001; 16(1): 102 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. El-Khairy, P. M Ueland, O. Nygard, H. Refsum, and S. E Vollset Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study Am. J. Clinical Nutrition, December 1, 1999; 70(6): 1016 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. ROSENQUIST, A. M. SCHNEIDER, and D. T. MONAGHAN N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities FASEB J, September 1, 1999; 13(12): 1523 - 1531. [Abstract] [Full Text]
|
|
|
|
 |
|
 M.F. Bellamy, I.F.W. McDowell, M.W. Ramsey, M. Brownlee, C. Bones, R.G. Newcombe, and M.J. Lewis Hyperhomocysteinemia After an Oral Methionine Load Acutely Impairs Endothelial Function in Healthy Adults Circulation, November 3, 1998; 98(18): 1848 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1833 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Mansoor, O. Kristensen, T. Hervig, P. A. Drablos, J. A. Stakkestad, L. Woie, O. Hetland, and A. Osland Low Concentrations of Folate in Serum and Erythrocytes of Smokers: Methionine Loading Decreases Folate Concentrations in Serum of Smokers and Nonsmokers Clin. Chem., November 1, 1997; 43(11): 2192 - 2194. [Full Text]
|
|
|
|
 |
|
 S. A. Lipton, W.-K. Kim, Y.-B. Choi, S. Kumar, D. M. D'Emilia, P. V. Rayudu, D. R. Arnelle, and J. S. Stamler Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor PNAS, May 27, 1997; 94(11): 5923 - 5928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Mudd, H. L. Levy, J. Selhub, A. Bostom, I. H. Rosenberg, M. J. Stampfer, and M. R. Malinow Plasma Homocyst(e)ine or Homocysteine? N. Engl. J. Med., August 3, 1995; 333(5): 325 - 325. [Full Text]
|
|
|
|
|
|
M. A. Mansoor, C. Bergmark, A. M. Svardal, P. E. Lonning, and P. M. Ueland Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease : Homocysteine and Peripheral Vascular Disease Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 232 - 240. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Undas, E. B. Williams, S. Butenas, T. Orfeo, and K. G. Mann Homocysteine Inhibits Inactivation of Factor Va by Activated Protein C J. Biol. Chem., February 2, 2001; 276(6): 4389 - 4397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Chambers, P. M. Ueland, M. Wright, C. J. Dore, H. Refsum, and J. S. Kooner Investigation of Relationship Between Reduced, Oxidized, and Protein-Bound Homocysteine and Vascular Endothelial Function in Healthy Human Subjects Circ. Res., July 20, 2001; 89(2): 187 - 192. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
